Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 4/20 | 0.34 |
| ▸ | RARB | P10826 | 3/20 | 0.34 |
| ▸ | RARG | P13631 | 3/20 | 0.34 |
| ▸ | RARA | P10276 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21115702 | 0.97 | CA1 (0.38) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21115695 | 0.97 | POLB (0.35) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21096713 | 0.92 | CA1 (0.36) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21097767 | 0.91 | CA1 (0.40) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL18645799 | 0.90 | POLB (0.32) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21097765 | 0.89 | CA1 (0.38) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21097763 | 0.89 | POLB (0.35) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21116077 | 0.87 | IDO1 (0.31) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL21097770 | 0.84 | RARB (0.38) | CA1CA2POLBAPEX1HTT | |
| SCHEMBL17070524 | 0.84 | RARB (0.36) | POLBAPEX1HTTTDP1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4249570-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2023-09-27 | — | — | EP | disclosed |
| EP-3877485-B1 | LIQUID CRYSTAL MEDIA COMPRISING POLYMERISABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| EP-3870671-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-08-09 | — | — | EP | disclosed |
| EP-3755764-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2023-05-10 | — | — | EP | disclosed |
| EP-3985085-A2 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-3944011-A1 | LIQUID-CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2022-01-26 | — | — | EP | disclosed |
| EP-3926023-A1 | LIQUID CRYSTAL MEDIA COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2021-12-22 | — | — | EP | disclosed |
| EP-3892706-A2 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
| EP-3666853-B1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2021-06-16 | — | — | EP | disclosed |
| EP-3604481-B1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2021-05-26 | — | — | EP | disclosed |
| EP-3816264-A1 | LIQUID CRYSTAL MEDIA COMPRISING POLYMERISABLE COMPOUNDS | Merck Patent GmbH (DE) | 2021-05-05 | — | — | EP | disclosed |
| EP-3789470-A1 | LIQUID CRYSTAL MEDIA COMPRISING POLYMERISABLE COMPOUNDS | Merck Patent GmbH (DE) | 2021-03-10 | — | — | EP | disclosed |
| EP-3502209-B1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2020-10-14 | — | — | EP | disclosed |
| EP-3502210-B1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2020-09-09 | — | — | EP | disclosed |
| EP-3666853-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2020-06-17 | — | — | EP | disclosed |
| EP-3604481-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2020-02-05 | — | — | EP | disclosed |
| EP-3502210-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
| EP-3502209-A1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | Merck Patent GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |